This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit August 26, 2015


 

Advertisement

Stress and cancer: Mindfulness is pivotal component to improve outcomes
Healio
Stress hormones are released when the body responds to physical, mental or emotional pressures. These stress hormones — such as epinephrine and norepinephrine — increase blood pressure, heart rate and blood glucose levels. Prior research suggests chronic stress may cause problems with the digestive system, as well as contribute to infertility, urinary issues and weakened immune systems. In addition, those with chronic stress are more susceptible to viral infections, headaches, sleep disturbances, depression and anxiety.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement


Promising target for new drugs found in pancreatic cancer cells
University of Houston via Medical Xpress
Pancreatic cancer is extremely deadly and often has a poor prognosis. Ranked as the fourth deadliest cancer in the U.S. and poised to move up within the next few years, pancreatic cancer is very difficult to detect in its early stages. Seldom diagnosed early, it typically spreading rapidly and has no effective treatment once it advances.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
SPONSORED CONTENT


Study: Reprogramming cancer cells back to normal looks feasible
Medical News Today
In many respects, cancer is like a complex software program of life that has gotten out of control; instead of the code for normal cells, a code for making abnormal cells is executed. Now, a new study in Nature Cell Biology suggests there may be a way to change the code so that cancer cells revert back to normal cells.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


NAPBC and CoC provide online poster to observe Breast Cancer Awareness Month
ACS
October is Breast Cancer Awareness Month. The National Accreditation Program for Breast Centers (NAPBC) and the Commission on Cancer (CoC) encourage your program to promote the event and use it as an opportunity to display/promote your accreditation status. To help you publicize this event within your program and the community, the NAPBC and the CoC have created a poster that you can download and print. Programs that are solely CoC accredited or accredited by both the CoC and NAPBC can access the poster by logging into CoC Datalinks and clicking on Marketing Resources Staff and NAPBC-accredited breast centers can log into the NAPBC portal and click on the "2015 Breast Cancer Awareness Month Poster" link in the "View Downloadable Center Resources" section to access the marketing resources Web page. For more information, contact srubin@facs.org.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  Benefits of NCBC Membership for Breast Care Physicians

Attention BREAST CARE Radiologists, Surgeons, Oncologists, OB/GYN’s and Pathologists... You are invited to become a Physician Member of the National Consortium of Breast Centers, a diversified group of over 2,000 breast health care professionals who exchange information, network and learn from each other.


 


Regorafenib not cost effective for third-line treatment of colorectal cancer
Cancer Therapy Advisor
Regorafenib for third-line management of metastatic colorectal cancer may provide minimal incremental benefit at high incremental cost per quality-adjust life-years, according to a recent study published online ahead of print in the Journal of Clinical Oncology. Researchers led by Daniel Goldstein, MD, of Emory University developed a Markov model in order to compare the cost-effectiveness of regorafenib compared with a placebo in these patients
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Missed an issue of The Brief? Click here to visit The Brief archive page.


Register now for Accreditation 101: Learning the Basics of CoC Accreditation and Standards
ACS
The Commission on Cancer (CoC), a Quality Program of the American College of Surgeons, encourages you to attend Accreditation 101: Learning the Basics of CoC Accreditation and Standards in Baltimore on Sept. 11. This program provides practical information on how to achieve compliance and discusses your role as a member of a patient-centered, multidisciplinary cancer care team. This is the only education program that is developed and taught by CoC surveyors and staff. Learn how to turn theory into reality and see how the CoC standards are a guide for the development of a high-quality program that treats patients with cancer. There's still time to register.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  insight2oncology™: Cancer Data at Your Fingertips
CHAMPS Oncology’s new web-based system transforms cancer data into actionable information for strategic planning, operational and financial decisions.
  • CHAMPS Seeks i2o™ Early Adopters
  • i2o™ Provides Answers to Cancer Service Lines’ Questions
  • Access 75+ Cancer Data Reports (Migration, Utilization & More)
 


Research trio outlines ways nanodiamonds are being used to treat cancer
Phys.Org
A trio of researchers, Dean Ho, with UCLA in the United States, Chung-Huei Katherine Wang, with BRIM Biotechnology Inc., in Taipei and Edward Kai-Hua Chow, with the National University of Singapore, has published a review in Science Advances of the ways nanodiamonds are being used in cancer research. They offer insights into the ways they may be used in the future.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Pre-order ACS Clinical Congress Webcasts and save
ACS
Register to attend the ACS Clinical Congress in Chicago, Oct. 4-8, and you can preorder the Webcasts today. This year's Clinical Congress includes more than 15 panel sessions in the Surgical Oncology Track that cover a variety of topics. For detailed information, please visit the Clinical Congress 2015 Web page. Note: Webcasts will be made available after Nov. 15. Purchase provides access to the 2015 Webcast sessions and expires Dec. 31, 2016.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Surgery, radiotherapy for early-stage breast cancer 'may not reduce mortality'
Medical News Today
A new study published in JAMA Oncology has questioned whether surgery and radiotherapy are appropriate for women in the earliest stages of breast cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Diagnostic model predicts impending death in patients with cancer
Healio
Researchers have developed a diagnostic model based on two objective bedside physical signs that predicts impending death within three days for patients with cancer. Using two variables as a foundation for the model — a palliative performance scale and the drooping of nasolabial folds, or the folds that run from the nose to the corner of the mouth — David Hui, MD, MSc, assistant professor in the department of palliative care and rehabilitation medicine in the division of cancer medicine at The University of Texas MD Anderson Cancer Center in Houston, and colleagues developed this model to help clinicians formulate their diagnosis of impending death.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Omega-3 fatty acids may improve treatment and quality of life in cancer patients
Oncology Nurse Advisor
Adding omega-3 fatty acids to antitumor medications may improve treatment response and quality of life for cancer patients. This new study was published in the Journal of Parenteral and Enteral Nutrition. The study, conducted by researchers at the University Hospitals of Leicester in the United Kingdom, examined 50 patients with advanced pancreatic cancer. Patients were given 1,000 mg of gemcitabine weekly followed by up to 100 grams of a lipid emulsion rich in omega-3 fatty acids for three weeks followed by a rest week. This process was continued for up to six cycles, progression, unacceptable toxicity, patient request or death.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword QUALITY OF LIFE.


Injectable, cryogel-based whole-cell cancer vaccines
Harvard University via Medical Xpress
New research led by Wyss Core Faculty member David Mooney, PhD, in collaboration with researchers at the Dana-Farber Cancer Institute could potentially yield a new platform for cancer vaccines. Leveraging a biologically inspired sponge-like gel called "cryogel" as an injectable biomaterial, the vaccine delivers patient-specific tumor cells together with immune-stimulating biomolecules to enhance the body's attack againstcancer. The approach, a so-called "injectable cryogel whole-cell cancer vaccine," was reported online in Nature Communications on Aug. 12.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Beta-blockers may improve survival in epithelial ovarian cancer
Oncology Nurse Advisor
Beta-blockers, particularly first-generation nonselective beta-blockers, improved overall survival among patients with epithelial ovarian cancer, according to a new study published in the journal Cancer. For the study, researchers from The University of Texas MD Anderson Cancer Center in Houston retrospectively analyzed the medical records of 1,425 women with epithelial ovarian cancer treated between 2000 and 2010 in order to evaluate the impact of beta-blocker use during chemotherapy on overall survival.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Young age and aggressive treatment in colon cancer (JAMA)
Chicago researchers roll out best practices for supportive care of cancer patients
(PR Newswire)
Regional node irradiation in breast cancer improves overall survival (Oncology Nurse Advisor)
Jimmy Carter's diagnosis: How the elderly fare with cancer (NBC News)
Lasers could help doctors diagnose cancer earlier, more reliably and less invasively (Tufts University via Medical Xpress)

Don't be left behind. Click here to see what else you missed.
 
Advertisement

Advertisement



The Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642
Contribute news

Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Aug. 19, 2015
Aug. 12, 2015
Aug. 5, 2015
July 22, 2015






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063